BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 21094027)

  • 1. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
    Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer.
    Liu T; Cheng T; Xu W; Yan WL; Liu J; Yang HL
    Skeletal Radiol; 2011 May; 40(5):523-31. PubMed ID: 20495798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.
    Chang MC; Chen JH; Liang JA; Lin CC; Yang KT; Cheng KY; Yeh JJ; Kao CH
    Acad Radiol; 2012 Mar; 19(3):349-57. PubMed ID: 22173321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X; Huang X; Yan W; Wu L; Dai K
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT.
    Liu T; Wang S; Liu H; Meng B; Zhou F; He F; Shi X; Yang H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):457-465. PubMed ID: 27752772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.
    Liu T; Xu W; Yan WL; Ye M; Bai YR; Huang G
    Radiother Oncol; 2007 Dec; 85(3):327-35. PubMed ID: 18037523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy.
    Yang HL; Liu T; Wang XM; Xu Y; Deng SM
    Eur Radiol; 2011 Dec; 21(12):2604-17. PubMed ID: 21887484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis.
    Cheng X; Li Y; Xu Z; Bao L; Li D; Wang J
    Acta Radiol; 2011 Sep; 52(7):779-87. PubMed ID: 21712464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer.
    Shie P; Cardarelli R; Brandon D; Erdman W; Abdulrahim N
    Clin Nucl Med; 2008 Feb; 33(2):97-101. PubMed ID: 18209527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
    Lin CY; Lin CL; Kao CH
    Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Shen G; Deng H; Hu S; Jia Z
    Skeletal Radiol; 2014 Nov; 43(11):1503-13. PubMed ID: 24841276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis.
    Zhou J; Gou Z; Wu R; Yuan Y; Yu G; Zhao Y
    Skeletal Radiol; 2019 Dec; 48(12):1915-1924. PubMed ID: 31127357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
    Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
    J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
    Bipat S; van Leeuwen MS; Comans EF; Pijl ME; Bossuyt PM; Zwinderman AH; Stoker J
    Radiology; 2005 Oct; 237(1):123-31. PubMed ID: 16100087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
    Sahin E; Zincirkeser S; Akcan AB; Elboga U
    J BUON; 2014; 19(1):291-6. PubMed ID: 24659678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.